Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research at the University of Oxford has shown that two digital cognitive behaviour therapies (CBTs) 'Sleepio' (targeting insomnia) and 'Daylight' (targeting generalised anxiety disorder) are effective and can be used as scalable interventions with wide ranging effects on mental health, wellbeing and workplace productivity.

These digital CBTs have been widely used across the UK since October 2018 to help more than 21,000 people, including NHS and social care staff during the COVID-19 pandemic, improve their sleep, wellbeing and mental health.

Since June 2019 and July 2020 respectively, Sleepio and Daylight have been made available through health insurers and occupational health programmes in the US and used by thousands of employees across 42 employers to improve workforce health and productivity.

Read the full impact case study